Interaction of Vav with ENX-1, a putative transcriptional regulator of homeobox gene expression

Molecular and Cellular Biology

Volumn 16, Issue 6, 1996, Pages 3066-3073

  Hobert, Oliver ^a,c   Jallal, Bahija ^b   Ullrich, Axel ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b SUGEN INC   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GENE PRODUCT VAV; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ENX 1; UNCLASSIFIED DRUG;

ARTICLE; GENE EXPRESSION; HOMEOBOX; HYBRID; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTO ONCOGENE; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION REGULATION;

EID: 0029899685     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.6.3066     Document Type: Article

References (43)

1. Aasland, R., T. J. Gibson, and A. F. Stewart. 1995. The PHD finger: implications for chromatin mediated transcriptional regulation. Trends Biochem. Sci. 20:56-59.
2. Adams, J. M., H. Houston, J. Allen, T. Lints, and R. Harvey. 1992. The hematopoietically expressed vav prolo-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organisation. Oncogcne 7:611-618.
3. Berg, J. M. 1990. Zinc fingers and other metal-binding domains. J. Biol. Chem. 265:6513-6516.
4. Brody, L. C., K. J. Abel, L. H. Castilla, F. J. Couch, D. R. Kinley, G. Y. Yin, P. P. Ho, S. Merajver, S. C. Chandrasekharappa, J. Xu, J. L. Cole, J. P. Struewing, J. M. Valdes, F. S. Collins, and B. L. Weber. 1995. Construction of a transcription map surrounding the BRCA1 locus of human chromosome 17. Genomics 25:238-247.
5. Bustelo, X. R., and M. Barbacid. 1992. Tyrosine phosphorylation of the vav proto-oncogene product in activated B-cells. Science 256:1196-1199.
6. Bustelo, X. R., J. A. Ledbetter, and M. Barbacid. 1992. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Nature (London) 356:68-71.
7. Bustelo, X. R., K.-L. Suen, W. M. Michael, G. Dreyfuss, and M. Barbacid. 1995. Association of the vav proto-oncogene product with poly(rC)-specific RNA-binding proteins. Mol. Cell. Biol. 15:1324-1332.
8. Care, A., U. Testa, A. Bassani, E. Tritarelli, E. Montesoro, P. Samoggia, L. Cianetti, and C. Peschle. 1994. Coordinate expression and proliferative role of HOXB genes in activated adult T lymphocytes. Mol. Cell. Biol. 14:4872-4877.
9. Clevenger, C. V., W. Ngo, D. L. Sokol, S. M. Luger, and A. M. Gewirtz. 1995. Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. J. Biol. Chem. 270:13246-13253.
10. Fields, S., and R. Sternglanz. 1994. The two-hybrid system: an assay for protein-protein interactions. Trends Genet. 10:286-292.
11. Fischer, K. D., A. Zmuidzinas, S. Gardner, M. Barbacid, A. Bernstein, and C. Guidos. 1995. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+CD8+ thymocytes. Nature (London) 374:474-477.
12. Franke, A., M. DeCamillis, D. Zink, N. Cheng, H. W. Brock, and R. Paro. 1992. Polycomb and polyhomeotic are constituents of a multimeric protein complex in chromatin of Drosophila melanogaster. EMBO J. 11:2941-2950.
13. Freemont, P. S. 1993. The RING finger. A novel protein sequence motif related to the zinc finger. Ann. N. Y. Acad. Sci. 684:174-192.
14. Freemont, P. S., I. M. Hanson, and J. Trousdale. 1991. A novel cysteine-rich sequence motif. Cell 64:483-484.
15. Friedman, L. S., E. A. Ostermeyer, E. D. Lynch, P. Welsch, C. I. Szabo, J. E. Meza, L. A. Anderson, P. Dowd, M. K. Lee, S. E. Rowell, J. Ellison, J. Boyd, and M. C. King. 1995. 22 genes form chromosome 17q21: cloning, sequencing and characterisation of mutations in breast cancer families and tumors. Genomics 25:256-263.
16. Hanazano, Y., K. Sasaki, H. Odai, T. Mimura, K. Mitani, Y. Yazaki, and H. Hirai. 1995. Tyrosine phosphorylation of the proto-oncogene product Vav and its association with the adaptor GRB2/Ash in human leukemia cell line UT-7. Jpn. J. Cancer Res. 86:336-341.
17. Haupt, Y., W. S. Alexander, G. Barri, S. P. Klinken, and J. M. Adams. 1991. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in Eμ-myc transgenic mice. Cell 65:753-763.
18. Hubert. O., B. Jallal, J. Schlessinger, and A. Ullrich. 1994. Novel signaling pathway suggested by SH3 domain-dependent p95vav/hnRNP-K interaction. J. Biol. Chem. 269:20225-20228.
19. 18a.Hobert, O., I. Sures, T. Ciossek, M. Fuchs, and A. Ullrich. Isolation and developmental expression analysis of Enx-1, a novel mouse Polycomb group gene. Mech. Dev., in press.
20. Jones, R. S., and W. M. Gelbart. 1993. The Drosophila Polycomb-group gene Enhancer of zeste contains a region with sequence similarity to trithorax. Mol. Cell. Biol. 13:6357-6366.
21. Karlin, S., and S. F. Altschul. 1990. Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. Proc. Natl. Acad. Sci. USA 87:2264-2268.
22. Karlin, S., and S. F. Altschul. 1993. Applications and statistics for multiple high-scoring segments and molecular sequences. Proc. Natl. Acad. Sci. USA 90:5873-5877.
23. Katzav, S., J. L. Cleveland, H. E. Heslop, and D. Pulido. 1991. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol. Cell. Biol. 11:1912-1920.
24. Katzav, S., D. Martin-Zanca, and M. Barbacid. 1989. Vav, a novel human oncogene derived from a locus ubiquitously expressed in haematopoietic cells. EMBO J. 8:2283-2290.
25. Kehrl, J. H. 1994. Homeobox genes in hematopoiesis. Crit. Rev. Oncol-Hematol. 16:145-156.
26. Lawrence, H. J., and C. Largman. 1992. Homeobox genes in normal hematopoiesis and leukemia. Blood 80:2445-2453.
27. Margolis, B., P. Hu, S. Katzav, W. Li, J. M. Olivier, A. Ullrich, A. Weiss, and J. Schlessinger. 1992. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs. Nature (London) 356:71-74.
28. Orlando, V., and R. Paro. 1995. Chromatin multiprotein complexes involved in the maintenance of transcription patterns. Curr. Opin. Genet. Dev. 5:174-179.
29. Osborne-Lawrence, S., P. L. Welsch, M. Spillman, S. C. Chandrasekharappa, T. D. Gallardo, M. Lovett, and A. M. Bowcock. 1995. Direct selection of expressed sequences within a 1-Mb region flanking BRCA1 on human chromosome 17q21. Genomics 25:248-255.
30. Ramos-Morales, F., B. J. Druker, and S. Fischer. 1994. Vav binds to several SH2/SH3 containing proteins in activated lymphocytes. Oncogene 9:1917-1923.
31. Rastelli, L., C. S. Chan, and V. Pirrotta. 1993. Related chromosome binding sites for zeste, suppressors of zeste and Polycomb group proteins in Drosophila and their dependence on Enhancer of zeste function. EMBO J. 12:1513-1522.
32. Reddy, B. A., L. D. Etkin, and P. S. Freemont. 1992. A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem. Sci. 17:344-345.
33. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
34. Sanchez-Garcia, I., and T. H. Rabbitts. 1994. The LIM domain: a new structural motif found in zinc-finger-like proteins. Trends Genet. 10:315-320.
35. Simon, J. 1995. Locking in stable states of gene expression: transcriptional control during Drosophila development. Curr. Opin. Cell Biol. 7:376-385.
36. Tarakhovsky, A., M. Turner, S. Schall, P. J. Mee, L. P. Duddy, K. Rajewsky, and V. L. J. Tybulewicz. 1995. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature (London) 374:467-470.
37. Tschiersch, B., A. Hofmann, V. Krauss, R. Dorn, G. Korge, and G. Reuter. 1994. The protein encoded by the Drosophila position-effect variegation suppressor gene Su(var)3-9 combines domains of antagonistic regulators of homeotic gene complexes. EMBO J. 13:3822-3831.
38. Valge-Archer, V. E., H. Osada, A. J. Warren, A. Forster, J. Li, R Baer, and T. H. Rabbitts. 1994. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc. Natl. Acad. Sci. USA 91:8617-8621.
39. van der Lugt, N. M. T., J. Domen, K. Linders, M. van Roon, E. Robanus-Maandag, H. te Riele, M. van der Walk, J. Deschamps, M. Sofroniew, M. van Lohuizen, and A. Berns. 1994. Posterior transformation, neurological abnormalities, and severe haematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev. 8:757-769.
40. van Lohuizen, M., S. Verbeek, B. Schegen, E. Wientjens, H. van der Gulden, and A. Berns. 1991. Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging. Cell 65:737-752.
41. Vojtek, A. B., S. M. Hollenberg, and J. A. Cooper. 1993. Mammalian ras interacts directly with the serine/threonine kinase raf. Cell 74:205-214.
42. Ye, Z.-S., and D. Baltimore. 1994. Binding of Vav to Grb2 through dimerization of Src homology 3 domains. Proc. Natl. Acad. Sci. USA 91:12629-12633.
43. Zhang, R., F. W. Alt, L. Davidson, S. H. Orkin, and W. Swat. 1995. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature (London) 374:470-473.